MALIGNANT PLEURAL EFFUSIONS (MPE)
Clinical trials for MALIGNANT PLEURAL EFFUSIONS (MPE) explained in plain language.
Never miss a new study
Get alerted when new MALIGNANT PLEURAL EFFUSIONS (MPE) trials appear
Sign up with your email to follow new studies for MALIGNANT PLEURAL EFFUSIONS (MPE), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental chest injection aims to stop cancer fluid buildup
Disease control Recruiting nowThis early study tests a drug called TolueneSulfonamide, injected directly into the chest cavity, to see if it can safely reduce fluid buildup in people with lung cancer. About 105 participants will receive the drug three times a week for one week. The goal is to control the flui…
Matched conditions: MALIGNANT PLEURAL EFFUSIONS (MPE)
Phase: PHASE1, PHASE2 • Sponsor: Gang Hou • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Lung cancer drug matching: lab test could personalize treatment
Knowledge-focused Recruiting nowThis study looks at whether testing lung cancer cells in a lab can predict which drugs will work best for each patient. Researchers will collect fluid from around the lungs of 400 people with lung cancer who need drainage for shortness of breath. They will grow the cancer cells i…
Matched conditions: MALIGNANT PLEURAL EFFUSIONS (MPE)
Sponsor: Sheba Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:03 UTC